# Iboga (Tabernanthe iboga)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/iboga
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** African
**Also Known As:** Tabernanthe iboga, Ibogaine root, Bwiti root, Eboga, Iboga root bark, African dream root, Tabernanthe manii

## Overview

Iboga (Tabernanthe iboga) is a West African shrub containing the psychoactive alkaloid ibogaine, traditionally used in Bwiti spiritual ceremonies. The plant affects multiple [neurotransmitter](/ingredients/condition/cognitive) systems including dopamine, [serotonin](/ingredients/condition/mood), and NMDA receptors, producing profound psychoactive effects.

## Health Benefits

• Traditional spiritual and introspective properties - used for centuries in Bwiti religion for initiatory rites (traditional evidence only)
• Potential stimulant effects - traditionally used for hunting [stamina](/ingredients/condition/energy) (traditional evidence only)
• No clinical trials or RCTs available in the research dossier to support specific health benefits
• Forensic detection studies exist but provide no therapeutic evidence
• Further clinical research needed to establish health benefits

## Mechanism of Action

Ibogaine, the primary alkaloid in iboga, acts as an antagonist at NMDA receptors and inhibits [serotonin](/ingredients/condition/mood) transporter function. It also modulates dopaminergic pathways in the brain's reward system and affects nicotinic [acetylcholine](/ingredients/condition/cognitive) receptors. These multi-receptor interactions contribute to its profound psychoactive and potentially therapeutic neurological effects.

## Clinical Summary

No clinical trials or randomized controlled studies have been conducted specifically on whole iboga root preparations. Most research focuses on isolated ibogaine rather than the complete plant extract. Traditional use evidence comes from ethnobotanical studies of Bwiti practitioners in Gabon and Cameroon, but lacks quantified dosing or standardized outcome measures. The absence of clinical data makes it impossible to verify traditional claims or establish safety profiles.

## Nutritional Profile

{"macronutrients": {"carbohydrates": "Not well-documented", "proteins": "Not well-documented", "fats": "Not well-documented"}, "micronutrients": {"vitamins": "Not well-documented", "minerals": "Not well-documented"}, "bioactive_compounds": {"ibogaine": "Approximately 6% of the dry weight of the root bark", "tabernanthine": "Present in trace amounts", "voacangine": "Present in trace amounts"}, "bioavailability_notes": "The bioavailability of ibogaine and other alkaloids is subject to significant first-pass [metabolism](/ingredients/condition/weight-management), and their absorption can vary widely among individuals."}

## Dosage & Preparation

No clinically studied dosage ranges are available in the research. Ibogaine comprises ~80% of total alkaloid extracts, with ibogaline up to 15% and ibogamine up to 5%. Semi-synthetic ibogaine HCl is produced from voacangine, but no standardization or dosing from studies is specified. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Iboga contains potent psychoactive compounds that can cause severe adverse effects including cardiac arrhythmias, seizures, and psychological distress. The plant is illegal in many countries due to its ibogaine content and associated fatalities. It should never be combined with other medications, particularly those affecting [heart rhythm](/ingredients/condition/heart-health) or central nervous system function. Pregnant and breastfeeding women should avoid iboga completely due to unknown but potentially severe developmental risks.

## Scientific Research

The research dossier provides no details on human clinical trials, RCTs, or meta-analyses for iboga or its alkaloids. Limited forensic data notes ibogaine and metabolite noribogaine detection in tissues post-administration via LC-MS, but this is not clinical trial evidence. No PubMed PMIDs for therapeutic studies are mentioned.

## Historical & Cultural Context

Iboga has been used for centuries in the Bwiti religion of Gabon and neighboring regions, primarily in initiatory rites for spiritual visions and introspection. Root bark is consumed in high doses for hallucinogenic/oneirogenic effects in rituals and as a stimulant for hunting [stamina](/ingredients/condition/energy).

## Synergistic Combinations

Not applicable - no synergistic ingredients identified in research

## Frequently Asked Questions

### What is the active compound in iboga?

Ibogaine is the primary psychoactive alkaloid in iboga, comprising 1-3% of the root bark. The plant also contains other alkaloids like ibogaline and tabernanthine that contribute to its overall effects.

### Is iboga legal in the United States?

No, iboga is federally illegal in the United States because it contains ibogaine, which is classified as a Schedule I controlled substance. Possession and distribution can result in serious criminal penalties.

### How is iboga used in traditional African ceremonies?

In Bwiti religion, iboga root bark is consumed in large quantities during initiation rites to induce visions and spiritual experiences. Ceremonies typically last 24-72 hours under guidance of experienced practitioners in Gabon and surrounding regions.

### What are the side effects of iboga?

Iboga can cause nausea, vomiting, tremors, cardiac irregularities, and intense psychological effects lasting many hours. Serious risks include heart failure, seizures, and death, with at least 19 documented fatalities associated with ibogaine use.

### Can iboga be used for addiction treatment?

While some underground practitioners claim iboga helps with addiction, there is no clinical evidence supporting its safety or efficacy for this purpose. The significant cardiac risks and lack of medical supervision make such use extremely dangerous.

### What is the current research status on iboga's safety and efficacy?

There are no completed clinical trials or randomized controlled studies (RCTs) in peer-reviewed literature establishing the safety or efficacy of iboga for any medical condition. Existing research is primarily limited to forensic detection studies and traditional ethnobotanical documentation, meaning therapeutic claims cannot be supported by clinical evidence. Anyone considering iboga should consult a healthcare provider, as the lack of clinical data means risks and benefits remain largely unknown.

### Who should avoid using iboga or consider it unsafe?

Iboga should be avoided during pregnancy, breastfeeding, and in children due to the absence of safety data in these populations. Individuals with cardiovascular conditions, seizure disorders, or those taking psychiatric medications should not use iboga without medical supervision, as serious adverse events have been reported. People with liver or kidney disease should also avoid iboga, as its metabolism and clearance are not well understood in these populations.

### How does iboga differ from other plant-based stimulants used traditionally?

Unlike caffeine-containing plants (coffee, tea, guarana) with established safety profiles and multiple clinical studies, iboga contains ibogaine—a complex alkaloid with hallucinogenic properties that has not undergone rigorous safety testing in supplement form. Traditional stimulant plants like ginseng or rhodiola have extensive clinical research supporting dosing and safety, whereas iboga lacks standardized formulations, validated dosages, or clinical evidence of efficacy for stamina. The regulatory and legal status of iboga also differs significantly from other traditional stimulants, making it unavailable in most mainstream supplement markets.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*